Mike Polark
Stock Analyst at Wolfe Research
(3.27)
# 953
Out of 4,884 analysts
75
Total ratings
45.83%
Success rate
4.15%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Upgrades: Peer Perform | n/a | $88.39 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $13.52 | +47.93% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $46.13 | +30.07% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $301.05 | +16.26% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $128.48 | +83.69% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $142.47 | +5.29% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $15.67 | +85.07% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $76.79 | -21.86% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $256.96 | -29.95% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $93.67 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $395.28 | +2.46% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $544.47 | -7.62% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $134.44 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $119.90 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $82.93 | +45.91% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $16.78 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $11.75 | +112.86% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $167.57 | -1.53% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $104.32 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.39 | +25.12% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $7.77 | +170.27% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $237.55 | +5.24% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.30 | +3,207.69% | 1 | Sep 2, 2020 |
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $88.39
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $13.52
Upside: +47.93%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $46.13
Upside: +30.07%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $301.05
Upside: +16.26%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $128.48
Upside: +83.69%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $142.47
Upside: +5.29%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $15.67
Upside: +85.07%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $76.79
Upside: -21.86%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $256.96
Upside: -29.95%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $93.67
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $395.28
Upside: +2.46%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $544.47
Upside: -7.62%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $134.44
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $119.90
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $82.93
Upside: +45.91%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $16.78
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $11.75
Upside: +112.86%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $167.57
Upside: -1.53%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $104.32
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $10.39
Upside: +25.12%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $7.77
Upside: +170.27%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $237.55
Upside: +5.24%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.30
Upside: +3,207.69%